Dr. James Anthony Krcik, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 486 Randall Rd Unit B, South Elgin, IL 60177 Phone: 224-361-4305 |
News Archive
Metabolex, Inc. announced today that they have entered into a global development and license agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. to further develop and discover compounds for the treatment of type 2 diabetes and other disorders. Under the agreement, OMJPI will receive an exclusive worldwide license to develop, manufacture, and commercialize several Metabolex programs that are currently at the preclinical stage.
Ever since the Nobel Prize for nerve growth factor was awarded more than 30 years ago, researchers have been searching for ways to use growth factor clinically.
Depression is common in cancer, up to half of all patients facing the disease experience depressive symptoms, ranging from mild to severe. When depression co-exists with cancer, patients may be at an increased risk of death from cancer and from suicide.
Published today in the open access European Journal of Psychotraumatology is a collection of articles that offer rare and unique insight into the often fiercely debated topic of deployment related PTSD and associated mental health problems.
Pharmion Corporation, along with its collaborator MethylGene Inc., today announced that the U.S. Food and Drug Administration (FDA) has designated the Companies' histone deacetylase (HDAC) inhibitor, MGCD0103, as an Orphan Drug for the treatment of Hodgkin's lymphoma in the United States.
› Verified 2 days ago